Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Sam-531
2. Way-262531
1. Sam-531
2. 925448-93-7
3. Way-262531
4. Pf-05212365
5. Cerlapirdine [usan]
6. N,n-dimethyl-3-[(3-naphthalen-1-ylsulfonyl-2h-indazol-5-yl)oxy]propan-1-amine
7. Sam-531 Free Base
8. Ek40pj0v49
9. 925448-93-7 (free Base)
10. Cerlapirdine (usan)
11. Way-262,531
12. N,n-dimethyl-3-((3-(naphthalen-1-ylsulfonyl)-2h-indazol-5-yl)oxy)propan-1-amine
13. Cerlapirdine [usan:inn]
14. Unii-ek40pj0v49
15. Sam531
16. Sam 531
17. Pf-5212365
18. Cerlapirdine [inn]
19. Cerlapirdine [who-dd]
20. Gtpl7356
21. Schembl3534330
22. Chembl2103880
23. Schembl21381542
24. Dtxsid201137232
25. Db12229
26. Hy-14431
27. Cs-0003354
28. D10099
29. Q5064514
30. Dimethyl-{3-[3-(naphthalene-1-sulfonyl)-1h-indazol-5-yloxy]-propyl}-amine
31. 1-propanamine, N,n-dimethyl-3-((3-(1-naphthalenylsulfonyl)-1h-indazol-5-yl)oxy)-
32. N,n-dimethyl-3-((3-((naphthalen-1-yl)sulfonyl)-1h-indazol-5-yl)oxy)propan-1-amine
33. N,n-dimethyl-3-((3-(1-naphthylsulfonyl)-1h-indazol-5-yl)oxy)propan-1-amine
34. N,n-dimethyl-3-((3-(naphthalen-1-ylsulfonyl)-1h-indazol-5-yl)oxy)propan-1-amine
| Molecular Weight | 409.5 g/mol |
|---|---|
| Molecular Formula | C22H23N3O3S |
| XLogP3 | 4.3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 7 |
| Exact Mass | 409.14601278 g/mol |
| Monoisotopic Mass | 409.14601278 g/mol |
| Topological Polar Surface Area | 83.7 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 636 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
A Cerlapirdine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cerlapirdine, including repackagers and relabelers. The FDA regulates Cerlapirdine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cerlapirdine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Cerlapirdine supplier is an individual or a company that provides Cerlapirdine active pharmaceutical ingredient (API) or Cerlapirdine finished formulations upon request. The Cerlapirdine suppliers may include Cerlapirdine API manufacturers, exporters, distributors and traders.
Cerlapirdine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cerlapirdine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cerlapirdine GMP manufacturer or Cerlapirdine GMP API supplier for your needs.
A Cerlapirdine CoA (Certificate of Analysis) is a formal document that attests to Cerlapirdine's compliance with Cerlapirdine specifications and serves as a tool for batch-level quality control.
Cerlapirdine CoA mostly includes findings from lab analyses of a specific batch. For each Cerlapirdine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cerlapirdine may be tested according to a variety of international standards, such as European Pharmacopoeia (Cerlapirdine EP), Cerlapirdine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cerlapirdine USP).
LOOKING FOR A SUPPLIER?
